Search Results - "Hamed, Kamal A"
-
1
Safety and pharmacokinetics of SPR206 in subjects with varying degrees of renal impairment
Published in Antimicrobial agents and chemotherapy (15-11-2023)“…SPR206 is a novel polymyxin derivative with potent activity against susceptible and multidrug-resistant strains of , , , , and species. SPR206 is eliminated…”
Get full text
Journal Article -
2
Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection
Published in Journal of antimicrobial chemotherapy (02-04-2024)“…Non-tuberculous mycobacterial pulmonary disease (NTM-PD) is increasing worldwide, with Mycobacterium avium complex (MAC) and Mycobacterium abscessus as the…”
Get full text
Journal Article -
3
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET)
Published in Clinical infectious diseases (05-10-2021)“…The development of novel broad-spectrum antibiotics, with efficacy against both gram-positive and gram-negative bacteria, has the potential to enhance…”
Get full text
Journal Article -
4
A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients
Published in The Pediatric infectious disease journal (01-06-2021)“…The advanced-generation, broad-spectrum, intravenous (IV) cephalosporin, ceftobiprole, is an effective and well-tolerated treatment for adults with…”
Get full text
Journal Article -
5
Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections
Published in Antimicrobial agents and chemotherapy (18-10-2023)“…ABSTRACT The clinical relevance of bacteriuria following antibiotic treatment of complicated urinary tract infections in clinical trials remains controversial…”
Get full text
Journal Article -
6
Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018
Published in Antimicrobial agents and chemotherapy (21-05-2020)“…Ceftobiprole medocaril is an advanced-generation cephalosporin prodrug that has qualified infectious disease product status granted by the US FDA and is…”
Get full text
Journal Article -
7
Ceftobiprole Activity against Gram-Positive and -Negative Pathogens Collected from the United States in 2006 and 2016
Published in Antimicrobial agents and chemotherapy (01-01-2019)“…Ceftobiprole is an advanced cephalosporin with potent activity against Gram-positive and Gram-negative bacteria that has been approved in many European and…”
Get full text
Journal Article -
8
Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020
Published in Diagnostic microbiology and infectious disease (01-07-2022)“…Bone and joint infections (BJIs) present significant treatment challenges. Ceftobiprole, a broad-spectrum cephalosporin with activity against…”
Get full text
Journal Article -
9
Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016–2017)
Published in Diagnostic microbiology and infectious disease (01-07-2019)“…Ceftobiprole medocaril, the prodrug of ceftobiprole, is an advanced-generation cephalosporin that is approved in many European and non-European countries for…”
Get full text
Journal Article -
10
Evaluation of Factors Predictive of Efficacy Among Patients With Complicated Urinary Tract Infection and/or Acute Pyelonephritis
Published in Open forum infectious diseases (01-09-2024)“…Abstract Background Antibiotic treatment for complicated urinary tract infections (cUTI)/acute pyelonephritis (AP) is often followed by recurrent bacteriuria…”
Get full text
Journal Article -
11
Successful Treatment of Primary Actinomyces viscosus Endocarditis with Third-Generation Cephalosporins
Published in Clinical infectious diseases (01-01-1998)Get full text
Journal Article -
12
Randomized, Investigator-Blinded, Multicenter, Comparative Study of Gatifloxacin Versus Amoxicillin/Clavulanate in Recurrent Otitis Media and Acute Otitis Media Treatment Failure in Children
Published in The Pediatric infectious disease journal (01-04-2005)“…BACKGROUND:Recurrent otitis media and acute otitis media treatment failure are commonly encountered in the pediatric population. OBJECTIVE:To compare the…”
Get full text
Journal Article -
13
Randomized, Investigator-Blinded, Multicenter Study of Gatifloxacin Versus Amoxicillin/Clavulanate Treatment of Recurrent and Nonresponsive Otitis Media in Children
Published in The Pediatric infectious disease journal (01-04-2005)“…BACKGROUND:Decreased susceptibility of pathogens to currently used agents for recurrent otitis media has provided the impetus for identifying new antimicrobial…”
Get full text
Journal Article -
14
Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women
Published in Clinical therapeutics (01-12-2002)“…Background: Trimethoprim/sulfamethoxazole (TMP/SMX) is currently the first choice for empiric therapy of acute uncomplicated urinary tract infection (UTI) in…”
Get full text
Journal Article -
15
Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study
Published in The Pediatric infectious disease journal (01-11-2003)“…BACKGROUND.Gatifloxacin is an 8-methoxyfluoroquinolone with good activity against respiratory pathogens. OBJECTIVES.To document the bacteriologic and clinical…”
Get full text
Journal Article -
16
-
17
-
18
Kaposi's sarcoma of the breast
Published in AIDS patient care and STDs (01-02-2000)“…Kaposi's sarcoma of the breast is extremely rare. We report a case of a patient with AIDS presenting with Kaposi's sarcoma localized to the breast and review…”
Get more information
Journal Article -
19
Haemophilus parainfluenzae Endocarditis: Application of a Molecular Approach for Identification of Pathogenic Bacterial Species
Published in Clinical infectious diseases (01-10-1994)“…Haemophilus parainfluenzae is both a human oropharyngeal commensal bacterium and a cause of serious invasive disease. The fastidious growth characteristics of…”
Get full text
Journal Article -
20
Pulmonary mucormycosis presenting as an endobronchial lesion
Published in Chest (01-12-1994)“…A 56-year-old diabetic man presented with left upper lobe collapse and postobstructive pneumonitis. Fiberoptic bronchoscopy revealed an endobronchial mass…”
Get more information
Journal Article